ATC
VRTX icon

Argent Trust Co’s Vertex Pharmaceuticals VRTX Stock Holding History

Argent Trust Co’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$901K Sell
2,017
-126
-6% -$58.8K 0.03% 364
2025
Q4 		$972K Sell
2,143
-40
-2% -$17.2K 0.03% 335
2025
Q3 		$855K Sell
2,183
-215
-9% -$89.9K 0.03% 358
2025
Q2 		$1.07M Sell
2,398
-506
-17% -$233K 0.04% 310
2025
Q1 		$1.41M Sell
2,904
-390
-12% -$182K 0.06% 265
2024
Q4 		$1.33M Buy
3,294
+1
+0% +$464 0.05% 272
2024
Q3 		$1.53M Buy
3,293
+49
+2% +$23.5K 0.06% 252
2024
Q2 		$1.52M Buy
3,244
+19
+0.6% +$8.25K 0.07% 245
2024
Q1 		$1.35M Buy
3,225
+217
+7% +$91.7K 0.06% 262
2023
Q4 		$1.22M Buy
3,008
+431
+17% +$159K 0.06% 250
2023
Q3 		$896K Buy
2,577
+90
+4% +$31.5K 0.05% 285
2023
Q2 		$875K Buy
2,487
+228
+10% +$76.8K 0.05% 298
2023
Q1 		$712K Hold
2,259
– – 0.05% 306
2022
Q4 		$652K Sell
2,259
-112
-5% -$34.1K 0.04% 309
2022
Q3 		$686K Sell
2,371
-40
-2% -$11.5K 0.05% 283
2022
Q2 		$680K Hold
2,411
– – 0.05% 296
2022
Q1 		$629K Sell
2,411
-350
-13% -$83.1K 0.04% 320
2021
Q4 		$606K Buy
2,761
+454
+20% +$88.3K 0.04% 332
2021
Q3 		$418K Sell
2,307
-130
-5% -$25.4K 0.03% 378
2021
Q2 		$491K Buy
2,437
+511
+27% +$107K 0.03% 344
2021
Q1 		$413K Sell
1,926
-230
-11% -$50.5K 0.03% 363
2020
Q4 		$510K Buy
2,156
+237
+12% +$54.4K 0.04% 316
2020
Q3 		$522K Sell
1,919
-18
-0.9% -$4.97K 0.05% 288
2020
Q2 		$563K Sell
1,937
-291
-13% -$78.9K 0.05% 266
2020
Q1 		$530K Sell
2,228
-117
-5% -$26.8K 0.06% 253
2019
Q4 		$514K Buy
2,345
+202
+9% +$40.9K 0.05% 294
2019
Q3 		$362K Buy
2,143
+1,000
+87% +$177K 0.03% 342
2019
Q2 		$209K Buy
+1,143
New +$200K 0.02% 420

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Argent Trust Co's VRTX Position: Q1 2026 in Review

Argent Trust Co reduced its Vertex Pharmaceuticals (VRTX) stake by 5.9% in Q1 2026, selling an estimated $58.8K and leaving 2,017 shares worth $901K. The position accounts for 0.03% of the portfolio, ranked #364.

Argent Trust Co first reported a position in VRTX in Q2 2019 and has held it in 28 quarters since. The position peaked at $1.53M in Q3 2024. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • Argent Trust Co held 2,017 shares of Vertex Pharmaceuticals worth $901K as of Q1 2026.
  • Argent Trust Co sold 126 Vertex Pharmaceuticals shares in Q1 2026, an estimated $58.8K.
  • Vertex Pharmaceuticals made up 0.03% of Argent Trust Co's portfolio in Q1 2026, its #364 holding.
  • Argent Trust Co first reported a position in Vertex Pharmaceuticals in Q2 2019 and has held it in 28 quarters since.
  • Argent Trust Co's Vertex Pharmaceuticals position peaked at $1.53M in Q3 2024.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Argent Trust Co's 13F filing for Q1 2026, filed 13 May 2026.